?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
518 Unternehmen gefunden • Seite 18 von 21
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xiangxue Pharmaceutical | 22.2 | Arzneimittel (Pharmazeutisch) | China | 0.6 Mrd. USD | - | 88.67 | 2.89 | -6.76 | ▼ -12.28% | - | - | ▼ -16.28% | 2 Jahre | -87.26% | ▼ -15.01% | -4.80% | ▲ 0.90% | 7.40% | ▲ 4.08% | 5 / 9 | −7,56 | −2,4-fach | 7 / 100 | −24,2 / 100 | −3,89 | |
| Hainan Haiyao Co Ltd | 22.2 | Arzneimittel (Pharmazeutisch) | China | 0.9 Mrd. USD | - | - | 8.65 | -46.05 | ▼ -17.69% | ▼ -5.82% | - | ▲ 31.95% | - | -51.73% | ▼ -10.69% | -23.58% | ▼ -4.95% | -7.63% | ▲ 0.19% | 6 / 9 | −5,82 | −2,8-fach | 4 / 100 | −9,0 / 100 | −3,22 | |
| Changchun BCHT Biotechnology Co. A | 22.2 | Arzneimittel (Pharmazeutisch) | China | 0.9 Mrd. USD | - | - | 10.10 | 1.63 | ▼ -16.31% | - | - | - | - | -45.97% | ▼ -13.05% | -61.26% | ▼ -16.26% | -29.62% | ▲ 3.51% | 5 / 9 | 4,01 | > 50-fach | 12 / 100 | −9,9 / 100 | −4,20 | |
![]() | Protalix Biotherapeutics Inc | 22.2 | Arzneimittel (Biotechnologie) | USA | 0.2 Mrd. USD | 11.23 | 27.74 | 2.64 | 2.98 | ▼ -3.46% | ▲ 0.25% | - | - | - | -12.52% | ▲ 15.56% | -10.43% | ▲ 12.05% | -25.84% | ▲ 7.72% | 4 / 9 | −10,92 | 2-fach | 31 / 100 | 6,5 / 100 | −0,11 |
| Hengkang Medical Group Co Ltd | 22.0 | Arzneimittel (Pharmazeutisch) | China | 1.1 Mrd. USD | 244.13 | - | 2.54 | 3.69 | ▲ 1.70% | - | - | - | - | 1.01% | ▲ 2.47% | 9.03% | ▲ 4.34% | 1.20% | ▼ -0.08% | 4 / 9 | −2,43 | 2-fach | 13 / 100 | −4,0 / 100 | −2,56 | |
| Chongqing Taiji Industry Group Co Ltd | 22.0 | Arzneimittel (Pharmazeutisch) | China | 1.1 Mrd. USD | 105.88 | 240.12 | 0.74 | 2.05 | ▼ -1.39% | ▲ 12.78% | - | - | - | 1.15% | ▲ 0.86% | 3.21% | ▲ 1.47% | 0.61% | ▼ -2.05% | 7 / 9 | −0,53 | 5-fach | 20 / 100 | −3,3 / 100 | −2,30 | |
![]() | Century Therapeutics Inc | 21.9 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | - | 3.06 | 1.46 | ▼ -25.33% | - | - | - | - | -8.78% | ▲ 1869.42% | -13.78% | ▲ 1838.64% | -95.93% | ▲ 2377.82% | 4 / 9 | −6,31 | −497,6-fach | 43 / 100 | 42,2 / 100 | 7,02 |
| Tonghua Golden-Horse Pharmaceutical Industry Co Ltd | 21.8 | Arzneimittel (Pharmazeutisch) | China | 2.3 Mrd. USD | 630.91 | - | 14.40 | 6.69 | ▲ 1.02% | - | - | - | - | 2.93% | ▲ 0.34% | 10.36% | ▲ 1.41% | 3.50% | ▼ -1.12% | 5 / 9 | 0,67 | 2-fach | 19 / 100 | −1,6 / 100 | −3,15 | |
![]() | Pacira BioSciences, Inc. | 21.7 | Arzneimittel (Pharmazeutisch) | USA | 1.0 Mrd. USD | 69.06 | 5.63 | 1.35 | 1.50 | ▲ 11.07% | ▼ -45.44% | - | - | - | 0.97% | ▼ -3.02% | 4.58% | ▼ -4.35% | 18.81% | ▲ 1.64% | 9 / 9 | 3,14 | 1-fach | 46 / 100 | −11,5 / 100 | −2,79 |
![]() | Ovid Therapeutics Inc | 21.5 | Arzneimittel (Biotechnologie) | USA | 0.5 Mrd. USD | - | - | 331.87 | 2.50 | ▼ -10.48% | ▼ -26.42% | - | - | - | -240.13% | ▼ -184.73% | -585.20% | ▼ -852.69% | -528.60% | ▼ -730.01% | 3 / 9 | 2,61 | - | 5 / 100 | 13,9 / 100 | - |
| Yipinhong Pharmaceutical Co Ltd Class A | 21.4 | Arzneimittel (Pharmazeutisch) | China | 2.3 Mrd. USD | 68.96 | - | 18.10 | 8.24 | ▼ -11.06% | - | - | ▲ 23.17% | 3 Jahre | -36.23% | ▼ -15.04% | -26.83% | ▼ -11.75% | -8.71% | ▼ -6.05% | 6 / 9 | 0,28 | −4,9-fach | 13 / 100 | −9,6 / 100 | −3,37 | |
| Zhejiang Huahai Pharmaceutical Co Ltd | 21.3 | Arzneimittel (Pharmazeutisch) | China | 3.4 Mrd. USD | 36.65 | - | 2.56 | 2.35 | ▲ 5.78% | ▼ -22.12% | 0.65% | - | - | 3.10% | ▼ -1.09% | 9.71% | ▼ -1.00% | -8.57% | ▲ 4.42% | 4 / 9 | 1,75 | 5-fach | 24 / 100 | −4,5 / 100 | −3,05 | |
![]() | Autolus Therapeutics Ltd | 21.1 | Arzneimittel (Biotechnologie) | Vereinigtes Königreich - UK | 0.5 Mrd. USD | - | - | 4.26 | 6.69 | ▲ 113.21% | ▲ 15.19% | - | - | - | -381.40% | ▲ 1831.78% | -372.45% | ▲ 1780.60% | -411.17% | ▲ 1560.08% | 5 / 9 | −6,15 | −7,0-fach | −4 / 100 | −0,8 / 100 | 2,86 |
![]() | Crispr Therapeutics AG | 21.0 | Arzneimittel (Biotechnologie) | Schweiz | 5.0 Mrd. USD | - | - | 373.43 | 2.86 | ▲ 37.31% | ▲ 10.76% | - | - | - | -16569.77% | ▲ 11485.40% | -16191.40% | ▲ 12059.71% | -9855.50% | ▲ 10200.69% | 2 / 9 | 6,68 | - | −10 / 100 | −10,4 / 100 | −6,41 |
![]() | Abcellera Biologics Inc | 21.0 | Arzneimittel (Biotechnologie) | Kanada | 3.5 Mrd. USD | - | - | 53.33 | 3.94 | ▼ -20.27% | - | - | - | - | -194.88% | ▼ -363.06% | -288.98% | ▼ -164.33% | -231.69% | ▼ -435.99% | 5 / 9 | 4,86 | - | 3 / 100 | −1,1 / 100 | −0,77 |
| Chongqing Zhifei Bio Products | 20.8 | Arzneimittel (Biotechnologie) | China | 4.5 Mrd. USD | - | 35.06 | 3.75 | 2.01 | ▼ -10.02% | - | - | - | - | -164.35% | ▼ -40.73% | -33.73% | ▼ -16.00% | 50.77% | ▲ 3.67% | 4 / 9 | 0,06 | −8,4-fach | 2 / 100 | −63,2 / 100 | −4,51 | |
| Shandong Buchang Pharmaceuticals Co Ltd | 20.7 | Arzneimittel (Pharmazeutisch) | China | 2.3 Mrd. USD | 64.71 | - | 1.36 | 1.52 | ▼ -5.80% | ▼ -27.97% | 3.94% | ▼ -5.01% | - | 3.04% | ▼ -0.51% | 12.43% | ▲ 0.88% | 8.71% | ▼ -0.19% | 9 / 9 | 2,63 | 3-fach | 38 / 100 | −4,0 / 100 | −3,76 | |
![]() | BridgeBio Pharma Inc | 20.7 | Arzneimittel (Biotechnologie) | USA | 14.2 Mrd. USD | - | - | 20.47 | -5.63 | ▲ 127.44% | ▲ 10.20% | - | - | - | -145.26% | ▲ 170.15% | -113.35% | ▲ 182.00% | -89.03% | ▲ 170.21% | 4 / 9 | −14,91 | −4,7-fach | 51 / 100 | −30,3 / 100 | 5,25 |
| Shenzhen Kangtai Biological Products Co Ltd | 20.5 | Arzneimittel (Pharmazeutisch) | China | 2.0 Mrd. USD | 157.77 | 271.87 | 5.14 | 1.36 | ▲ 3.40% | ▼ -36.46% | 0.30% | - | - | 2.63% | ▼ -5.21% | 9.40% | ▼ -4.38% | 11.36% | ▲ 10.05% | 8 / 9 | 4,59 | 4-fach | 14 / 100 | −4,0 / 100 | −2,97 | |
| Dizal (Jiangsu) Pharmaceutical Co. Ltd. A | 20.4 | Arzneimittel (Pharmazeutisch) | China | 3.7 Mrd. USD | - | - | 33.47 | 21.85 | ▲ 81.20% | ▲ 11.38% | - | - | - | -95.37% | ▲ 1031.32% | -94.91% | ▲ 1149.34% | -94.71% | ▲ 894.44% | 5 / 9 | −2,71 | −44,7-fach | 26 / 100 | −5,9 / 100 | −0,38 | |
| North China Pharmaceutical Co Ltd | 20.3 | Arzneimittel (Pharmazeutisch) | China | 1.3 Mrd. USD | 68.68 | - | 1.04 | 1.54 | ▼ -4.27% | ▲ 13.47% | 0.71% | - | 2 Jahre | 1.98% | ▲ 1.15% | 7.20% | ▲ 2.03% | 6.87% | ▲ 0.42% | 6 / 9 | −0,82 | 2-fach | 14 / 100 | −5,0 / 100 | −3,25 | |
![]() | Bayer AG NA | 20.3 | Arzneimittel (Pharmazeutisch) | Deutschland | 54.8 Mrd. USD | - | 32.64 | 1.04 | 1.60 | ▲ 1.94% | ▼ -19.18% | 0.23% | ▼ -44.01% | - | -7.94% | ▼ -3.41% | 15.26% | ▼ -1.21% | 4.57% | ▼ -0.04% | 6 / 9 | 0,44 | −0,3-fach | 24 / 100 | −7,4 / 100 | −2,35 |
![]() | Travere Therapeutics Inc | 20.0 | Arzneimittel (Biotechnologie) | USA | 6.2 Mrd. USD | - | 212.59 | 10.55 | 254.35 | ▲ 19.87% | ▼ -31.50% | - | - | - | -5.21% | ▲ 37.93% | -12.80% | ▲ 43.02% | -4.15% | ▲ 10.16% | 7 / 9 | −5,11 | −21,4-fach | 79 / 100 | −10,5 / 100 | −1,71 |
![]() | Moderna Inc | 19.8 | Arzneimittel (Biotechnologie) | USA | 57.5 Mrd. USD | - | - | 25.80 | 8.50 | ▲ 47.92% | ▲ 30.45% | - | - | - | -145.16% | ▼ -58.35% | -158.13% | ▼ -63.94% | -106.22% | ▼ -51.39% | 3 / 9 | 5,29 | −142,3-fach | 9 / 100 | −7,7 / 100 | −3,49 |
| Journey Medical Corp | 19.7 | Arzneimittel (Pharmazeutisch) | USA | 0.2 Mrd. USD | - | - | 2.99 | 6.35 | ▲ 6.79% | - | - | - | - | -18.48% | ▲ 11.65% | -13.21% | ▲ 9.71% | -20.11% | ▲ 0.09% | 4 / 9 | −1,36 | −2,5-fach | 39 / 100 | 1,1 / 100 | −0,88 |